-
-
-
-
-
-
-
T2 Biosystems (TTOO) Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens
-
-
-
-
-
-
-
T2 Biosystems (TTOO) Files $150M Mixed Shelf
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

